Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 2, 1996, Pages 94-98

  Jorgensen, C ^a   Picot, M C ^b   Bologna, C ^a   Sany, J ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROLACTIN;

ADULT; AGED; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PARITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030030989     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.2.94     Document Type: Article

References (29)

1. Cecere F A, Perselin R H. The interaction of pregnancy and the rheumatic diseases. Clin Rheum Dis 1981; 7: 747-68.
2. Kaplan D, Diamond H. Rheumatoid arthritis and pregnancy. Clin Obstet Gynecol 1965; 8: 286-91.
3. Klipple G L, Cecere F A. Rheumatoid arthritis and pregnancy. Rheum Dis N Am 1989; 15: 213-39.
4. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983; 12: 69-72.
5. Oka M. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis 1953; 73: 227-9.
6. Silman A J. Is pregnancy a risk factor in the causation of rheumatoid arthritis? Ann Rheum Dis 1986; 45: 1031-4.
7. Brennan P, Silman A. Breast feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994; 37: 808-13.
8. Hazes J M W, Dijizmans B A C, Vandenbroucke J P, DeVries R R P, Cats A. Pregnancy and the risk of RA. Arthritis Rheum 1990; 33: 1770-5.
9. Berczi I, Nagy E, Asa S, Kovacs K. The inflence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 1984; 27: 682-8.
10. Whyte A, Williams R O. Bromocriptine suppresses postpartum exacerbation of collagen induced arthritis. Arthritis Rheum 1988; 31: 927-8.
11. Chikanza I C, Panayi G S. Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide. Br J Rheumatol 1991; 30: 203-7.
12. Zeben D, Hazes J M W, Vandenbroucke J P, Dijksman B A C, Cats A. Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum 1990; 33: 1462-5.
13. Hazes J M W, Dijkmans B A C, Vandenbroucke J P, Vries R R P, Cats A. Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum 1990; 33: 173-9.
14. Spector T D, Roman E, Silman A J. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990; 33: 782-9.
15. Linos A, Worthington J W, O'Fallon W N. Case control study of rheumatoid arthritis and prior use of oral contraceptive. Lancet 1983; i: 1299-300.
16. Spector T D, Hochberg M C. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using metaanalysis. J Clin Epidemiol 1990; 43: 1221-30.
17. Jorgensen C, Sany J. Modulation of the immune response by the neuroendocrine axis in rheumatoid arthritis. Clin Exp Rheumatol 1994; 12: 435-41.
18. Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. Seguret F, Daures J P, Guizard A V, et al. Herault breast cancer screening program: results after 30 months of the mobile French schedule. Eur J Cancer Prev 1995. In press.
20. Ritchie P M, Boyle J A, McInnes J M. Clinical studies with an articular index for the assessement of joint tenderness in patients with RA. Q J Med 1969; 3: 393-406.
21. Larsen A, Dale K, Eek M. Radiographic evaluation of RA and related conditions by standard reference films. Acta Radiol Diag 1977; 18: 488-91.
22. Cutolo M, Accardo S, Villaggio B, et al. Presence of estrogen binding sites on macrophage like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum 1993; 36: 1087-97.
23. Vandenbroucke J P, Witteman J C M, Valkenbourg H A, Boersma J W, Cats A, Festen J J M. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and post menopausal women. JAMA 1986; 255: 1299-303.
24. Felbo M, Snorrasson E. Pregnancy and the place of therapeutic abortion in rheumatoid arthritis. Acta Obstet Gynecol Scand 1961; 8: 116-26.
25. Oka M, Vaino U. Effect of pregnancy on prognosis and serology of rheumatoid arthritis. Acta Rheum Scand 1966; 12: 47-53.
26. Brun J G, Nilssen S, Kvales G. Breast feeding, other reproductive factors and rheumatoid arthritis. A prospective study. Br J Rheumatol 1995; 34: 542-6.
27. Jorgensen C, Bressot N, Lefebre P, Bologna C, Suquet J, Sany J. Dysregulation of the pituitary adrenal axis and of the pituitary prolactin synthesis in rheumatoid arthritis. J Rheumatol 1995. In press.
28. Unger A, Kay A, Griffin A J, Panayi G S. Disease activity and pregnancy associated α2 glycoprotein in rheumatoid arthritis during pregnancy. BMJ 1983; 5: 750-2.
29. Stanworth DR. A possible immunochemical explanation for pregnancy associated remissions in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 89-90.